BAFF   Click here for help

GtoPdb Ligand ID: 5069

Synonyms: B cell-activating factor | CD257 antigen | dendritic cell-derived TNF-like molecule
Immunopharmacology Ligand
Comment: The TNFSF13B precursor is also cleaved into a soluble form of the ligand.
Species: Human
Natural/Endogenous Targets
Target
BAFF receptor
B cell maturation antigen
TACI
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
TACI Ligand is endogenous in the given species Hs None - - - -
BAFF receptor Ligand is endogenous in the given species Hs None - - - -
B cell maturation antigen Ligand is endogenous in the given species Hs None - - - -
Selectivity at ligand targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
blisibimod Primary target of this compound Hs None Binding 11.4 pKd - 5
pKd 11.4 (Kd 4x10-12 M) [5]
Description: Binding to human AGP3 (=BAFF)
atacicept Primary target of this compound Hs None Binding 9.9 – 10.1 pKd - 6
pKd 9.9 – 10.1 (Kd 1.35x10-10 – 9x10-11 M) [6]
Description: Competitive binding to [125I]BAFF.
Other ligands which bind to or alter the activity of this ligand
Key to terms and symbols Click column headers to sort
Ligand Sp. Type Action Value Parameter Concentration range (M) Reference
tibulizumab Peptide Primary target of this compound Hs Antibody Binding 10.2 pKd - 1
pKd 10.2 (Kd 6x10-11 M) [1]
tabalumab Peptide Primary target of this compound Hs Antibody Binding 8.0 pKd - 3
pKd 8.0 (Kd 1x10-8 M) [3]
belimumab Peptide Approved drug Primary target of this compound Hs Antibody Binding 10.6 pEC50 - 2
pEC50 10.6 (EC50 2.4x10-11 M) [2]
Description: Binding affinity to immobilised BLyS
telitacicept Peptide Approved drug Hs Fusion protein Binding - - - 8
[8]